BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11775411)

  • 1. [Interaction between congestive heart failure and diabetes mellitus: critical review of the literature].
    Ferrua S; Bobbio M; Grassi G; Trevi G
    Ital Heart J Suppl; 2001 Nov; 2(11):1192-200. PubMed ID: 11775411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
    Fonarow GC
    Am J Med; 2004 Mar; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of the diabetic patient with prior cardiovascular events.
    Fonarow GC
    Rev Cardiovasc Med; 2003; 4 Suppl 6():S38-49. PubMed ID: 14668702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
    Sarafidis PA; Bakris GL
    QJM; 2006 Jul; 99(7):431-6. PubMed ID: 16766516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus and heart failure.
    Choy CK; Rodgers JE; Nappi JM; Haines ST
    Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I; Liu P; Webb G
    Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in diabetic patients: utility of beta-blockade.
    Kirpichnikov D; McFarlane SI; Sowers JR
    J Card Fail; 2003 Aug; 9(4):333-44. PubMed ID: 13680555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapeutic strategy in heart failure.
    Dominiak P
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S2-6. PubMed ID: 12227721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic versus non-ischemic heart failure: should the etiology be determined?
    Follath F
    Heart Fail Monit; 2001; 1(4):122-5. PubMed ID: 12634896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure and diabetes: pathogenesis and management.
    Kamalesh M
    Minerva Med; 2006 Jun; 97(3):231-9. PubMed ID: 16855518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.